NCT06038682 Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure Status COMPLETED Phase N/A
NCT06033560 The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure Status UNKNOWN Phase N/A
NCT06030414 A Study to Determine the Tolerability of Intranasal LMN-301 Status COMPLETED Phase PHASE1
NCT06027229 Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations Status COMPLETED Phase PHASE2
NCT06022224 A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL Status TERMINATED Phase PHASE2/PHASE3
NCT06020118 Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations Status COMPLETED Phase PHASE4
NCT06016556 A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia Status COMPLETED Phase N/A
NCT06008860 A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection Status RECRUITING Phase PHASE4
NCT06008470 Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection Status COMPLETED Phase N/A
NCT06006884 A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae Status RECRUITING Phase N/A
NCT06006858 Post Authorization Safety Study Moderna COVID-19 Primary Vaccine Status COMPLETED Phase N/A
NCT06006845 Time to Initiated Antitumor Therapy for Tumor Patients With COVID19 Infection Status UNKNOWN Phase N/A
NCT06006611 Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study Status UNKNOWN Phase N/A
NCT06004375 THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL Status COMPLETED Phase PHASE3
NCT06004323 Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities and Chinese People With Chronic Illnesses in Hong Kong Status UNKNOWN Phase NA
NCT06004128 Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments Status NO_LONGER_AVAILABLE Phase N/A
NCT05997511 Leveraging Community Health Workers to Combat COVID-19 and Mental Health Misinformation in Haiti, Malawi, and Rwanda Status ACTIVE_NOT_RECRUITING Phase NA
NCT05997290 A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals Status COMPLETED Phase PHASE2/PHASE3